Extraction and Socket Preservation Before Implant Placement Using Freezed Dried Allograft (FDBA) and Platelet-Rich Fibrin in Smokers
1 other identifier
interventional
40
1 country
1
Brief Summary
the investigators aim from this study to evaluate platelet rich fibrin potential to heal the periodontal tissue and to form new native bone in smokers that require socket augmentation following dental extraction and before implant placement. Materials and Methods: 18 adult smoker patients with 40 extracted sockets were recruited for this study, and the extracted sockets were distributed into four different groups as follows; Group 1- A-PRF alone, Group 2- Factors-enriched bone graft matrix (commonly known as sticky bone) using autologous fibrin glue combined with an FDBA with CGF-Enriched Fibrin Membrane to covered it, Group 3- an FDBA with a crosslinked collagen membrane and Group 4-Resorbable collagen plug (RCP) alone serving as a negative control group. The patients were randomly grouped into a previously mentioned group, and the socket dimensions were measured four times, immediately after the extraction (0 days), after 10, 21, and 28 days to assess epithelial layer healing. After six months and before placing the implant fixture, both soft and hard tissue samples will be harvested to be evaluated and compared histologically, also standardized CBCT will be taken before and after extraction to evaluate the amount of mineral content and vital bone formation radiographically.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 7, 2021
CompletedFirst Submitted
Initial submission to the registry
November 12, 2021
CompletedFirst Posted
Study publicly available on registry
December 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 2, 2023
CompletedMay 12, 2023
May 1, 2023
1.8 years
November 12, 2021
May 10, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
soft tissue healing and migration.
In all groups, the buccolingual and mesiodistal dimensions at the osseous crest of the extraction socket will be measured at the midpoints immediately after extraction with a University of Michigan O Probe with Williams marking (Hu-Friedy® Mfg Chicago, IL, USA) at 0, 10, 21, and 28 days.
28 days
bone height after ridge preservation.
two different measurements shall be taken at baseline and after 6 months using Cone-beam computed tomography to asess vertical resorption measured by mean difference in length of socket.
6 months
bone width after ridge preservation.
two different measurements shall be taken at baseline and after 6 months using Cone-beam computed tomography to asess the mean width ridge difference between outer border of buccal and lingual cortical plate at Socket depth at 1, 3,5 mm.
6 months
Study Arms (4)
A-PRF
EXPERIMENTALA-PRF+ allograft bone
EXPERIMENTALallograft bone+crosslinked collagen membrane
ACTIVE COMPARATORcollagen plug
SHAM COMPARATORInterventions
we would like to measure the effect of PRF on soft and hard tissue healing
Eligibility Criteria
You may qualify if:
- Current smokers
- have at least one tooth indicated for extraction due to extensive decay, tooth fracture or failed root canal treatment.
- years of age or older.
- give a written consent to participate in the trial.
- have the desire to have an implant restoration for at least one non-restorable tooth
- indicated for socket preservation procedures and generally healthy with no systematic disease
You may not qualify if:
- subjects who unable to undergo oral surgery procedures due to a medical condition.
- women who are pregnant or nursing a child.
- subjects with dental infection of bone, active periodontal disease and ankylosed teeth.
- Subjects with following systemic diseases and conditions: Chemotherapy or radiation for the treatment of cancer and arthritis, seriously impaired cardiovascular or pulmonary function, uncontrolled diabetes, auto-immune compromised diseases, kidney or liver disease and history of severe, multiple allergies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
King Saud University
Riyadh, 12211, Saudi Arabia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor, PHD student
Study Record Dates
First Submitted
November 12, 2021
First Posted
December 17, 2021
Study Start
June 7, 2021
Primary Completion
March 20, 2023
Study Completion
May 2, 2023
Last Updated
May 12, 2023
Record last verified: 2023-05